medigraphic.com
ISSN 2448-8747 (Print)
Publicación cuatrimestral editada por la Secretaría de Salud Jalisco

2020, Number 3

<< Back Next >>

Sal Jal 2020; 7 (3)

Influenza A (H1N1): Un nuevo desafío, que llegó para quedarse…

Sánchez-Espinoza A; Corona-Núñez TJ, Rojo-Contreras EW, Aguilar-Madrigal F, Reyes-Vélez MN

Language: Spanish
References: 50
Page: 164-172
PDF size: 271.82 Kb.


ABSTRACT

Influenza is a very contagious respiratory disease caused by influenza viruses. It can infect the upper respiratory tract (nose and throat) or even infect the lower respiratory tract (lungs), causing severe pneumonia. The most important event about influenza was the “2009 H1N1” pandemic, caused by influenza A H1N1. Historic year that sparked a revolution in what was previously believed to be influenza, a very contagious infection with low mortality, and what today we consider one of the viral infections with greatest capacity of population damage. Historically in the Jalisco Delegation, the Regional General Hospital (HGR) 110, of the Mexican Social Security Institute (IMSS), since the beginning of the pandemic was documented until november 30, 2009, an increase in cases of atypical pneumonia was observed, with a clinical picture compatible with influenza, which required hospitalization and even admission to the Intensive Care Unit. Complications that arise from a viral influenza infection are many, they can become severe and even fatal; for this reason it will be necessary to know the population groups with the highest risk to present complications, emphasize in pregnant women, whom in our country represent a priority care group and forces us to sharpen our senses when we detect them. Encourage the timely start of antiviral therapy with Oseltamivir or Zanamivir, which improves the clinical outcome of a patient hospitalized for influenza. And note that the best way to treat influenza is to avoid complications, through primary vaccine prevention.


REFERENCES

  1. Alejandro Rodríguez a,b,*, Th iago Lisboa a, Emili Díaz a, Jordi Rello a y Cristóbal León c,d. De la seguridad a la prevención: gripe A (H1N1), un nuevo desafío para los intensivistas. Medicina intensiva 2009;33(6):265-266

  2. Older Age and a Reduced Likelihood of 2009 H1N1 Virus Infection. N Engl J Med 12,2009:361;20

  3. La gripe española. La pandemia de 1918-1919. B. Echeverri. CISSiglo XXI, Madrid, 1993.

  4. Osores Plenge F, Gómez Benavides J, Suarez Ognio L, Cabezas Sánchez C, Alave Rosas J, Maguiña Vargas C. Un nuevo virus A/ H1N1, una nueva pandemia: Infl uenza un riesgo permanente para una humanidad globalizada. Scielo. Acta Med Per 26 (2) 2009

  5. Organización Panamericana de la Salud. Preguntas frecuentes sobre la Pandemia (H1N1) 2009. [monografía en Internet], 2009 [citado 11 de noviembre 2009], Disponible en: http://new.paho.org/hq/index.php?option=com_ content&task=blogcategory&id=805&Itemid=569&lang=es

  6. Alonso Reynoso, C. La infl uenza A (H1N1) y las medidas adoptadas por las autoridades sanitarias. Scielo Analytics Sep 2009. ISSN 2448-5144versión impresa ISSN 1607-050X

  7. Seema Jain, M.D., Laurie Kamimoto, M.D., M.P.H., Anna M. Bramley, M.P.H., Ann M. Schmitz, D.V.M.Stephen R. Benoit, M.D., M.P.H., Janice Louie, M.D., M.P.H., David E. Sugerman, M.D., M.P.H.,Jean K. Druckenmiller, B.S., S.M.(N.R.M.), Kathleen A. Ritger, M.D., M.P.H., Rashmi Chugh, M.D., M.P.H., Supriya Jasuja, M.D., M.P.H., Meredith Deutscher, M.D., Sanny Chen, Ph.D., M.H.S., John D. Walker, M.D.,Jeff rey S. Duchin, M.D., Susan Lett, M.D., M.P.H., Susan Soliva, M.P.H., Eden V. Wells, M.D., M.P.H.,David Swerdlow, M.D., Timothy M. Uyeki, M.D., M.P.H., Anthony E. Fiore, M.D., M.P.H., Sonja J. Olsen, Ph.D.,Alicia M. Fry, M.D., M.P.H., Carolyn B. Bridges, M.D., Lyn Finelli, Dr.P.H., for the 2009 Pandemic Infl uenza A (H1N1) Virus Hospitalizations Investigation Team* Hospitalized Patients with 2009 H1N1 Infl uenza in the United States, April–June 2009. N Engl J Med 2009;361

  8. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 infl uenza A (H1N1) infection in Canada. JAMA 2009; 302:1872–1879.

  9. Dabanch Jeannette. Infl uenza A (H1N1) 2009: pandemia en Chile. Medwave 2010 Abr;10(04):e4493 doi: 10.5867/ medwave.2010.04.4493

  10. Th ompson WW, Shay DK, Weintraub E, et al. Infl uenza-associated hospitalizations in the United States. JAMA 2004;292:1333--40.

  11. Poehling KA, Edwards KM, Weinberg GA, et al. Th e underrecognized burden of infl uenza in young children. N Engl J Med 2006;355:31--40.

  12. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with infl uenza infection. JAMA 2005;294:2188--94.

  13. Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jeringan DB. Prevention and Control of seasonal Infl uenza with Vaccines: Recommendations of the Advisory Committee on Inmmunization Practices- United States, 2018-19 Infl uenza Season. MMWR Recomm Rep 2018;67 (No. RR-3):1-20 DOI: http://dx.doi.org/10.15585/mmwr.rr6703a1

  14. IMSS. Guía de práctica clínica. Prevención, Diagnóstico y Tratamiento de la Infl uenza A (H1N1). 2009 ISBN: 978-607- 7790-20-4

  15. Torres-Ramírez, A. La infl uenza pandémica A(H1N1) en mujeres embarazadas. 2010. Ginecol Obstet Mex 2010;78(2):121-127

  16. Soria J, Solari L, Cabezas C, Ticona E. Guía para el Manejo de Pacientes con la Nueva Infl uenza A(H1N1). Rev Peru Med Exp Salud Publica. 2009; 26(3): 349-57.

  17. Toro Montoya A, Aguirre Muñoz C. Infl uenza A: La clínica y el laboratorio. Medicina & Laboratorio, Volumen 15, Números 3-4, 2009.

  18. Belenguer-Muncharaz A, Reig-Valero R, Altaba-Tena S, Casero- Roig P y Ferrándiz-Sellés A. Utilizació n de la ventilació n mecá nica no invasiva en neumoní a grave por virus H1N1. Med Intensiva. 2011;35(8):470-477

  19. Chartrand C, Leefl ang MM, Minion J, Brewer T, Pai M. Accuracy of rapid infl uenza diagnostic tests: a meta-analysis. Ann Intern Med. 3 de abril de 2012;156(7):500-11.

  20. Merckx J, Wali R, Schiller I, Caya C, Gore GC, Chartrand C et al. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Infl uenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Metaanalysis. Ann Intern Med. 2017 Sep 19;167(6):394-409.

  21. Juan Carlos Neri Salvador,*,** Lina Marcela Barranco Garduñ o,** Hé ctor Leó n Molina,** Alejandro Tovar Serrano,* Mario Enrique Rendó n Mací as,*** Francisco Javier Flores Murrieta** . Factores predictores de defunció n en pacientes con neumoní a por infl uenza a H1n1. Med Int Mex 2011;27(5):421-428

  22. Carrillo Bayona J, Bacca Campillo H, Botero Gutiérrez M, Almonacid Araque J et al. Manifestaciones clínicas y radiológicas de infección respiratoria por virus de infl uenza A H1N1Infl uenza A H1N1 virus respiratory infection: Clinical and radiological manifestations. Infectio Volume 18, Issue 1, January–March 2014, Pages 12-21

  23. Pan American Health Organization. Consideraciones y recomendaciones provisionales para el manejo clínico de la infl uenza pandémica (H1N1) 2009. Consulta de expertos de OPS/OMS. Julio 2009

  24. Pautas preliminares para las precauciones de aislamiento: prevención del contagio de agentes infecciosos en los ámbitos de cuidados de salud. Recomendaciones del Comité Asesor sobre Prácticas de Control de Infecciones en los Cuidados de Salud (HICPAC), CDC. Agosto 2009. Disponible en: https://espanol. cdc.gov/enes/flu/professionals/infectioncontrol/resphygiene. htm

  25. Banda-Lara M, Hidalgo-Loperena H, Rivera-Benitez C. Severidad de la neumonía asociada a infl uenza A H1N1: Evaluación de escalas de severidad. Rev Med Hospital General de México. Vol. 74. Núm. 1.páginas 3-8 (Enero 2011)

  26. Sparo M, Delpech G, Schell C, De luca, M, Basualdo Farjat. Neumonías bacterianas bacteriémicas post-infl uenza. SEDICI. Tercera Época; vol. 2, no 1. Octubre 2010

  27. Fiore A, Fry A, Shay D, Gubareva L, Bresse J, Uyeki T. Antiviral Agents, for the Treatment and Chemoprophylaxis of Infl uenza. CDC, MMWR Recommendations and Reports/Vol. 60/ No.1. Enero 2011.

  28. Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jeringan DB. Prevention and Control of seasonal Infl uenza with Vaccines: Recommendations of the Advisory Committee on Inmmunization Practices- United States, 2018-19 Infl uenza Season. MMWR Recomm Rep 2018;67 (No. RR-3):1-20 DOI: http://dx.doi.org/10.15585/mmwr.rr6703a1

  29. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 infl uenza in the United States, April--June 2009. N Engl J Med 2009; 361:1935--44.

  30. Lee N, Cockram CS, Chan PKS, et al. Antiviral treatment for patients hospitalized with severe infl uenza infection may aff ect clinical outcomes. Clin Infect Dis 2008; 46:1323--4.

  31. Welliver R, Monto AS, Carewicz O, et al. Eff ectiveness of oseltamivir in preventing infl uenza in household contacts: a randomized controlled trial. JAMA 2001; 285:748--54.

  32. Nicholson KG, Aoki FY, Osterhaus AD, et al. Effi cacy and safety of oseltamivir in treatment of acute infl uenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000; 355:1845--50.

  33. Treanor JJ, Hayden FG, Vrooman PS, et al. Effi cacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute infl uenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283:1016--24.

  34. Villa Grajeda KK, Gutiérrez Román EA, Guzmán Pantoja JE. Infl uenza AH1N1. Terapéutica Farmacológica. ATEN FAM 2009; 16 (4-5)

  35. Hayden FG, Gubareva LV, Monto AS, et al. Inhaled zanamivir for the prevention of infl uenza in families. Zanamivir Family Study Group. N Engl J Med 2000; 343:1282--9.

  36. Debra Birnkrant, M.D., and Edward Cox, M.D., M.P.H.Th e Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Infl uenza. N engl j med 2009; 361;23

  37. Guía de Práctica Clínica. Prevención, Diagnóstico y Tratamietno de la Neumonía Adquirida en la Comunidad en Adultos. Evidencias y Recomendaciones. Nú mero de Registro: IMSS-234-09

  38. Celica L. Irrazabal1, Abelardo A. Capdevila1, Carlos Sosa1, Et Al. Síndrome De Distres Respiratorio Agudo Utilidad De Los Corticoides1 Medicina (Buenos Aires) 2004; 64: 250-256.

  39. Raúl Carrillo-Esper, Estatinas en infl uenza. Momento de un estudio clínico controlado. Cir Ciruj 2009;77:351-352

  40. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 infl uenza A (H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303:1517--25.

  41. Creanga AA, Johnson TF, Graitcer SB, et al. Severity of 2009 pandemic infl uenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010; 115:717--26.

  42. Louie JK, Acosta M, Jamieson DJ, et al. Severe 2009 H1N1 infl uenza in pregnant and postpartum women in California. N Engl J Med 2009; 362:27--35.

  43. 209 Rasmussen SA, Jamieson DJBresee JS. Pandemic infl uenza and pregnant women. Emerg Infect Dis 2008;14:95--100.

  44. Callaghan WM, Chu SY, Jamieson DJ. Deaths from seasonal infl uenza among pregnant women in the United States, 1998-- 2005. Obstet Gynecol 2010;115:919--23.

  45. Harris J. Infl uenza occurring in pregnant women: a statistical study of thirteen hundred and fi ft y cases. JAMA 1919;72:978--80.

  46. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 infl uenza virus infection during pregnancy in the USA. Lancet 2009;374:451--8.

  47. CENAPRECE. Plan Nacional para la Prevención y Respuesta ante la Intensifi cación de la Infl uenza Estacional o ante una Pandemia de Infl uenza. Disponible en: http://www.cenaprece.salud.gob.mx/ programas/interior/emergencias/descargas/pdf/Plan_Nacional_ Infl uenza.pdf

  48. Talledo M, Zemaeta K. Los virus infl uenza y la nueva pandemia A/H1N1. Rev. peru. biol. 16(2): 227 - 238 (Diciembre 2009) ISSN 1727-9933

  49. Macías-Richard C. Respuestas institucionales y corporativas a la pandemia de 2009. Amércica Latina ante los actores multinacionales en la producción de medicamentos. Desacatos, núm. 32, enero-abril 2010, pp. 63-88

  50. González-Duarte A, Ponde de León Rosales, S. Asociación del syndrome de Guillain-Barré y la vacuna de infl uenza A (H1N1). Rev Fac Med UNAM Vol. 53 No. 2 Marzo-Abril, 2010.




2020     |     www.medigraphic.com